United Cannabis Corporation Expanding its International Patent Protection For Processes Related to its Prana Product Line
April 20 2017 - 4:20PM
Access Wire
National Stage Applications Upon PCT/US2015/056635
Are Currently in the Process of Being Filed in Australia, Brazil,
Canada, China, Colombia, Europe, Eurasia, India, Israel, Japan,
Mexico, New Zealand, the Philippines, South Africa, and South
Korea
DENVER, CO / ACCESSWIRE / April 20, 2017 /
United Cannabis Corporation (OTCQB: CNAB) (the "Company" or "United
Cannabis"), the creator of Prana Bio Nutrient Medicinals, today
announced that it is expanding protection of its intellectual
properties, and National Stage applications based upon
PCT/US2015/056635, and pursuant to the Patent Cooperation Treaty
(PCT), for "Cannabis Extracts and Methods of Preparing and Using
Same" are currently in the process of being filed in Australia,
Brazil, Canada, China, Colombia, Europe, Eurasia, India, Israel,
Japan, Mexico, New Zealand, the Philippines, South Africa and South
Korea.
The processes included in the filing are integral to the
Company's branded products, including the Prana Bio Nutrient
Medicinals line, and comprise the application of strain specific
ratio based phytocannabinoids, cannabinoids, chemical-free
extractions, and the use of cannabis derived terpenes in the
medical and pharmaceutical delivery methods, including capsules,
sublinguals, topicals, transdermal applications, supplements,
edibles, aerosol sprays, nebulizers, inhalers, aromatherapy,
suppositories, and vaporization.
Tony Verzura, United Cannabis' Chief Technology Officer,
commented on the filing, "We have always taken a scientific
approach to medical cannabis, with the objective of providing
patients with the highest quality product. This philosophy touches
every aspect of our operation - from the genetics we use to
acceptable cultivation practices, to the extraction techniques,
delivery mechanisms and formulations we create - as we seek to
maximize the bioavailability of each of our product profiles. As we
broaden our presence in the market, it is critical that we protect
the proprietary nature of our intellectual property, as well as the
anticipated financial returns on our investment."
Mr. Verzura went on to say, "These filings will expand the
existing international protection of our proprietary processes as
well as secure the safe licensing of these technologies to
interested parties around the world. I expect that we will file for
additional patents branching off from this foundation as regulation
develops in other countries around the world."
PCT is an international treaty that provides patent protection
simultaneously in more than 145 Contracting States through a single
application, rather than filing separate national or regional
patent applications. The acceptance of the application by PCT
establishes a filing date in all contracting states, providing the
Company with a precedent against any future competing filings.
About United Cannabis Corporation
United Cannabis Corporation is a biotechnology company dedicated
to the development of phyto-therapeutic based products supported by
patented technologies for the pharmaceutical, medical, and
industrial markets. The Company is a pioneer in the application of
cannabinoids for medical applications and is building a platform
for designing targeted therapies to increase the quality of life
for patients around the world. The Company's products are patent
protected, first in class medicines with applications to a global
market. United Cannabis trades on the OTCQB under the symbol
CNAB.
For further information, please visit www.unitedcannabis.us.
Contact: Staff@UnitedCannabis.us
Phone: 303-386-7321
Certain statements in this news release may contain
forward-looking information within the meaning of Rule 175 under
the Securities Act of 1933, and are subject to Rule 3b-6 under the
Securities Exchange Act of 1934, and are subject to the safe harbor
created by those rules. All statements, other than statements of
fact, included in this release, including, without limitation,
statements regarding potential future plans and objectives of the
company, are forward-looking statements that involve risks and
uncertainties. There can be no assurance that such statements will
prove to be accurate and other results and further events could
differ materially from those anticipated in such statements. Future
events and actual results could differ materially from those set
forth in, contemplated by, or underlying the forward-looking
statements.
SOURCE: United Cannabis Corporation